Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ABBV AbbVie
- 175.580
- +4.060+2.37%
Close Dec 20 16:00 ET
- 175.580
- 0.0000.00%
Post 20:01 ET
310.27BMarket Cap61.18P/E (TTM)
176.800High170.660Low18.95MVolume171.794Open171.520Pre Close3.32BTurnover1.08%Turnover Ratio64.55P/E (Static)1.77BShares207.32052wk High51.44P/B309.37BFloat Cap148.29452wk Low6.13Dividend TTM1.76BShs Float207.320Historical High3.49%Div YieldTTM3.58%Amplitude20.016Historical Low175.239Avg Price1Lot Size
AbbVie News
AbbVie | 8-K: Kevin K. Buckbee Plans to Retire as AbbVie's Controller
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | 8-K: Guidance Including the Impact of Acquired IPR&D and Milestones Expense (Unaudited)
AbbVie | 8-K: Current report
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense
AbbVie | 8-K/A: Poll Results of AbbVie Meeting (Amendment)
AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense
AbbVie | DEF 14A: Definitive information statements
AbbVie | DEFA14A: Others
AbbVie | PRE 14A: Preliminary proxy statements relating to merger or acquisition
AbbVie | 8-K: Closure of Notes Sale Pursuant to Underwriting Agreement
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | 8-K: AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
AbbVie | 8-K: AbbVie Completes Acquisition of ImmunoGen
AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense (Unaudited)
AbbVie | 8-K: AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
AbbVie | 8-K: Abbvie to Acquire Immunogen, Including Its Flagship Cancer Therapy Elahere® (Mirvetuximab Soravtansine-Gynx), Expanding Solid Tumor Portfolio
AbbVie | 8-K: Abbvie Appointed Jennifer Davis as a Class II Director and Susan Quaggin as a Class III Director
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.